Search Results - "Wang, Sa A"

Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults by Jain, Nitin, Roberts, Kathryn G., Jabbour, Elias, Patel, Keyur, Eterovic, Agda Karina, Chen, Ken, Zweidler-McKay, Patrick, Lu, Xinyan, Fawcett, Gloria, Wang, Sa A., Konoplev, Sergej, Harvey, Richard C., Chen, I-Ming, Payne-Turner, Debbie, Valentine, Marcus, Thomas, Deborah, Garcia-Manero, Guillermo, Ravandi, Farhad, Cortes, Jorge, Kornblau, Steven, O'Brien, Susan, Pierce, Sherry, Jorgensen, Jeffrey, Shaw, Kenna R.Mills, Willman, Cheryl L., Mullighan, Charles G., Kantarjian, Hagop, Konopleva, Marina

“…Philadelphia chromosome (Ph)-like acute lymphoblastic leukemia (ALL) is a high-risk subtype of ALL in children. There are conflicting data on the incidence and…”
Get full text

Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study by Kantarjian, Hagop, Prof, Thomas, Deborah, MD, Jorgensen, Jeffrey, MD, Jabbour, Elias, MD, Kebriaei, Partow, MD, Rytting, Michael, MD, York, Sergernne, RN, Ravandi, Farhad, MD, Kwari, Monica, RN, Faderl, Stefan, MD, Rios, Mary Beth, RN, Cortes, Jorge, MD, Fayad, Luis, MD, Tarnai, Robert, PhD, Wang, Sa A, MD, Champlin, Richard, MD, Advani, Anjali, MD, O'Brien, Susan, MD

“…Summary Background The outlook for patients with refractory and relapsed acute lymphocytic leukaemia (ALL) is poor. CD22 is highly expressed in patients with…”
Get full text

Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients by Khanlari, Mahsa, Yin, C. Cameron, Takahashi, Koichi, Lachowiez, Curtis, Tang, Guilin, Loghavi, Sanam, Bah, Ismael, Wang, Wei, Konoplev, Sergej, Medeiros, L. Jeffrey, Pemmaraju, Naveen, Khoury, Joseph D., Wang, Sa A.

“…Myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML) are reported in up to 20% patients with blastic plasmacytoid dendritic cell neoplasm…”
Get full text

DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma by Qiu, Lianqun, Tang, Guilin, Li, Shaoying, Vega, Francisco, Lin, Pei, Wang, Sa A, Wang, Wei, Iyer, Swaminathan P, Malpica, Luis, Miranda, Roberto N, Konoplev, Sergej, Tang, Zhenya, Fang, Hong, Medeiros, L Jeffrey, Xu, Jie

“…DUSP22 rearrangement (R) has been associated with a favorable outcome in systemic ALK-negative anaplastic large cell lymphoma (ALCL). However, a recent study…”
Get full text

Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms by Wang, Sa A., Hasserjian, Robert P., Fox, Patricia S., Rogers, Heesun J., Geyer, Julia T., Chabot-Richards, Devon, Weinzierl, Elizabeth, Hatem, Joseph, Jaso, Jesse, Kanagal-Shamanna, Rashmi, Stingo, Francesco C., Patel, Keyur P., Mehrotra, Meenakshi, Bueso-Ramos, Carlos, Young, Ken H., Dinardo, Courtney D., Verstovsek, Srdan, Tiu, Ramon V., Bagg, Adam, Hsi, Eric D., Arber, Daniel A., Foucar, Kathryn, Luthra, Raja, Orazi, Attilio

“…Atypical chronic myeloid leukemia (aCML) is a rare subtype of myelodysplastic/myeloproliferative neoplasm (MDS/MPN) largely defined morphologically. It is,…”
Get full text

Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm by Wang, Wei, Khoury, Joseph D, Miranda, Roberto N, Jorgensen, Jeffrey L, Xu, Jie, Loghavi, Sanam, Li, Shaoying, Pemmaraju, Naveen, Nguyen, Than, Medeiros, L Jeffrey, Wang, Sa A

“…Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematopoietic neoplasm whose immunophenotype remains incompletely characterized, particularly in…”
Get full text

Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology by Arber, Daniel A, Borowitz, Michael J, Cessna, Melissa, Etzell, Joan, Foucar, Kathryn, Hasserjian, Robert P, Rizzo, J Douglas, Theil, Karl, Wang, Sa A, Smith, Anthony T, Rumble, R Bryan, Thomas, Nicole E, Vardiman, James W

“…- A complete diagnosis of acute leukemia requires knowledge of clinical information combined with morphologic evaluation, immunophenotyping and karyotype…”
Get full text

CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia by Angelova, Evgeniya, Audette, Charlene, Kovtun, Yelena, Daver, Naval, Wang, Sa A, Pierce, Sherry, Konoplev, Sergej N, Khogeer, Haitham, Jorgensen, Jeffrey L, Konopleva, Marina, Zweidler-McKay, Patrick A, Medeiros, L Jeffrey, Kantarjian, Hagop M, Jabbour, Elias J, Khoury, Joseph D

“…The potential of CD123-targeted therapies in acute lymphoblastic leukemia/lymphoma remains largely unexplored. We examined CD123 expression levels in a large…”
Get full text

Persistent IDH1/2 mutations in remission can predict relapse in patients with acute myeloid leukemia by Ok, Chi Young, Loghavi, Sanam, Sui, Dawen, Wei, Peng, Kanagal-Shamanna, Rashmi, Yin, C Cameron, Zuo, Zhuang, Routbort, Mark J, Tang, Guilin, Tang, Zhenya, Jorgensen, Jeffrey L, Luthra, Rajyalakshmi, Ravandi, Farhad, Kantarjian, Hagop M, DiNardo, Courtney D, Medeiros, L Jeffrey, Wang, Sa A, Patel, Keyur P

“…Persistence of or mutations in remission bone marrow specimens of patients with acute myeloid leukemia has been observed, but the clinical impact of these…”
Get full text

Acute myeloid leukemia with mast cell differentiation is characterized by interstitial mast cells, complex karyotype, TP53 alterations and poor prognosis by Kim, Do Hwan, Wang, Sa A, Wang, Wei, Tang, Guilin, Li, Shaoying, Yin, C Cameron, Lin, Pei, Konopleva, Marina, You, M James, Miranda, Roberto N, Wang, Xiaoqiong, Wei, Qing, Medeiros, L Jeffrey, Xu, Jie

Get full text

Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia by Tanaka, Tomoyuki, Morita, Kiyomi, Loghavi, Sanam, Wang, Feng, Furudate, Ken, Sasaki, Yuya, Little, Latasha, Gumbs, Curtis, Matthews, Jairo, Daver, Naval, Pemmaraju, Naveen, DiNardo, Courtney D., Sasaki, Koji, Yilmaz, Musa, Kadia, Tapan M., Ravandi, Farhad, Konopleva, Marina Y., Kantarjian, Hagop M., Champlin, Richard E., Al-Atrash, Gheath, Garcia-Manero, Guillermo, Wang, Sa A., Futreal, P. Andrew, Takahashi, Koichi

“…Although clonal hematopoiesis (CH) can precede the development of acute myeloid leukemia (AML), it can also persist after achieving remission. Long-term clonal…”
Get full text

T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis by Fang, Hong, Beird, Hannah C., Wang, Sa A., Ibrahim, Andrew F., Tang, Zhenya, Tang, Guilin, You, M. James, Hu, Shimin, Xu, Jie, Li, Shaoying, Yin, C. Cameron, El Hussein, Siba, Le, Nhi, Futreal, P. Andrew, Bueso-Ramos, Carlos, Thakral, Beenu, Kadia, Tapan M., Thornton, Rebecca, Little, Latasha, Gumbs, Curtis, Song, Xingzhi, Medeiros, L. Jeffrey, Wang, Wei

Get full text

More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia by Montalban-Bravo, Guillermo, Benton, Christopher B., Wang, Sa A., Ravandi, Farhad, Kadia, Tapan, Cortes, Jorge, Daver, Naval, Takahashi, Koichi, DiNardo, Courtney, Jabbour, Elias, Borthakur, Gautam, Konopleva, Marina, Pierce, Sherry, Bueso-Ramos, Carlos, Patel, Keyur, Kornblau, Steven, Kantarjian, Hagop, Young, Ken H., Garcia-Manero, Guillermo, Andreeff, Michael

Get full text

Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases by Fang, Hong, Wang, Sa A, Khoury, Joseph D, El Hussein, Siba, Kim, Do Hwan, Tashakori, Mehrnoosh, Tang, Zhenya, Li, Shaoying, Hu, Zhihong, Jelloul, Fatima Zahra, Patel, Keyur P, McDonnell, Timothy J, Kadia, Tapan, Medeiros, L Jeffrey, Wang, Wei

Get full text

Results of a 2‐arm, phase 2 clinical trial using post‐transplantation cyclophosphamide for the prevention of graft‐versus‐host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation by Gaballa, Sameh, Ge, Isabell, El Fakih, Riad, Brammer, Jonathan E., Kongtim, Piyanuch, Tomuleasa, Ciprian, Wang, Sa A., Lee, Dean, Petropoulos, Demetrios, Cao, Kai, Rondon, Gabriela, Chen, Julianne, Hammerstrom, Aimee, Lombardi, Lindsey, Alatrash, Gheath, Korbling, Martin, Oran, Betul, Kebriaei, Partow, Ahmed, Sairah, Shah, Nina, Rezvani, Katayoun, Marin, David, Bashir, Qaiser, Alousi, Amin, Nieto, Yago, Qazilbash, Muzaffar, Hosing, Chitra, Popat, Uday, Shpall, Elizabeth J., Khouri, Issa, Champlin, Richard E., Ciurea, Stefan O.

“…BACKGROUND High‐dose, post‐transplantation cyclophosphamide (PTCy) to prevent graft‐versus‐host disease (GVHD) has improved outcomes in haploidentical (HAPLO)…”
Get full text

Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRD by Thompson, Philip A., Keating, Michael J., Ferrajoli, Alessandra, Jain, Nitin, Peterson, Christine B., Garg, Naveen, Wang, Sa A., Jorgensen, Jeffrey L., Kadia, Tapan M., Bose, Prithviraj, Pemmaraju, Naveen, Short, Nicholas J., Wierda, William G.

“…Patients receiving ibrutinib for CLL rarely achieve undetectable measurable residual disease (U-MRD), necessitating indefinite therapy, with cumulative risks…”
Get full text

Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome by Wang, Sa A, Hasserjian, Robert P, Tam, Wayne, Tsai, Albert G, Geyer, Julia T, George, Tracy I, Foucar, Kathryn, Rogers, Heesun J, Hsi, Eric D, Rea, Bryan A, Bagg, Adam, Bueso-Ramos, Carlos E, Arber, Daniel A, Verstovsek, Srdan, Orazi, Attilio

“…Chronic eosinophilic leukemia, not otherwise specified can be difficult to distinguish from idiopathic hypereosinophilic syndrome according to the current…”
Get full text

Unique pathologic features and gene expression signatures distinguish blastoid high-grade B-cell lymphoma from B-acute lymphoblastic leukemia/lymphoma by Qiu, Lianqun, Xu, Jie, Lin, Pei, Cohen, Evan N, Tang, Guilin, Wang, Sa A, Khanlari, Mahsa, Wang, Wei, Khoury, Joseph D, Konoplev, Sergej, Yin, C Cameron, Jorgensen, Jeffrey L, Vega, Francisco, Medeiros, L Jeffrey, Li, Shaoying

Get full text

Acute Myeloid Leukemia and Myelodysplastic Syndromes After Radiation Therapy Are Similar to De Novo Disease and Differ From Other Therapy-Related Myeloid Neoplasms by NARDI, Valentina, WINKFIELD, Karen M, CHI YOUNG OK, NIEMIERKO, Andrzej, KLUK, Michael J, ATTAR, Eyal C, GARCIA-MANERO, Guillermo, WANG, Sa A, HASSERJIAN, Robert P

“…Therapy-related myeloid neoplasms (t-MN) represent a unique clinical syndrome occurring in patients treated with chemotherapy and/or external-beam radiation…”
Get full text

STAT5B mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia by Yin, C Cameron, Tam, Wayne, Walker, Serena M, Kaur, Amandeep, Ouseph, Madhu M, Xie, Wei, K Weinberg, Olga, Li, Peng, Zuo, Zhuang, Routbort, Mark J, Chen, Simon, Medeiros, L Jeffrey, George, Tracy I, Orazi, Attilio, Arber, Daniel A, Bagg, Adam, Hasserjian, Robert P, Wang, Sa A

“…STAT5B has been reported as a recurrent mutation in myeloid neoplasms with eosinophilia, but its overall frequency and importance across a spectrum of myeloid…”
Get full text